|
Medical News Synthesized Protein Could Aid Tuberculosis TreatmentApril 26, 2005 Researchers believe that "waking up" dormant TB bacteria in the body could make treatment of the disease quicker and more effective. In a new study, University College London (UCL) researchers analyzed the molecular structure of resuscitation promoting factor (RpF) within the TB bacterium; they believe that a synthesized version of that protein could activate dormant bacteria. "The antibiotics we give to patients are effective in killing active TB bacteria but not ones that are lying dormant," said Dr. John Ward, of UCL's Department of Biochemistry and Molecular Biology. "People feel better quickly after starting their treatment course, which should last six months, and then they stop taking their medication," he said. "But four or five months later, the bacteria lying dormant in the body is activated." "We need to unlock the secrets behind the RpF protein and mimic its effect in a molecule that we can give orally -- so that we can wake up all the bacteria -- in the same way that we give antibiotics," said Ward. "It's not the cure for TB but these dormant TB bacteria have been a problem." The full report, "The Structure of a Resuscitation-Promoting Factor Domain from Mycobacterium tuberculosis Shows Homology to Lysozymes," was published in Nature Structural & Molecular Biology (2005;12:270-273). BBC News 04.15.2005 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
|